氧雄龙致烧伤患者转氨酶升高的发生率
单中心回顾性风险因素分析纳入66例使用氧雄龙的烧伤患者,以AST或ALT>100mg/dL定义转氨酶升高,28例(42%)发生转氨酶升高;转氨酶升高组合并使用其他有转氨酶升高风险药物的比例显著更高(p=0.045),两组肝功能障碍或住院时长无显著差异。
要点
- 氧雄龙相关转氨酶升高发生率为42%(28/66),高于既往报道。
- 转氨酶升高组并用其他有转氨酶升高风险药物的比例显著更高(p=0.045)。
- 两组肝功能障碍及住院时长无显著差异。
核心结论
- 氧雄龙诱导的转氨酶升高在烧伤患者中发生率显著高于既往报道,需进一步研究监测要求、并用药物及转氨酶恢复后是否再挑战。
研究设计与样本
- 单中心回顾性风险因素分析,比较使用氧雄龙后发生与未发生转氨酶升高的烧伤患者,共66例。
主要发现
- 28/66(42%)患者发生转氨酶升高。
- 转氨酶升高组合并使用其他有转氨酶升高风险药物的比例显著更高(p=0.045)。
- 两组肝功能障碍或住院时长无显著差异。
关键数值与推荐
- 转氨酶升高定义为AST或ALT>100mg/dL。
临床怎么用
- 使用氧雄龙的烧伤患者应关注转氨酶升高风险,尤其是并用其他有转氨酶升高风险药物时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The benefits of oxandrolone in burn patients has led to its accepted use in the burn care community, however details regarding the most common adverse effect, transaminitis, remains unclear. The purpose of this study was to determine the incidence of transaminitis in patients with burn injury and identify risk factors associated with the development of transaminitis. This single-center, retrospective risk factor analysis compared burn patients on oxandrolone with and without the development of transaminitis, defined as any aspartate aminotransferase or alanine aminotransferase value >100mg/dL. Patient demographics, past medical history, lab values, and burn characteristics were recorded. Overall 28 out of 66 (42%) patients developed transaminitis. The transaminitis group had a significantly higher proportion of other concomitant medications with a transaminitis risk (p=0.045). No significant difference in liver dysfunction or length of stay was observed between the two groups. Oxandrolone induced transaminitis is occurring in patients significantly more frequently than previously reported warranting further research to guide monitoring requirements, use of concomitant medications, and to determine if rechallenging after resolution should be considered.
引用
- Kiracofe B, Coffey R, Jones LM, et al. Incidence of oxandrolone induced hepatic transaminitis in patients with burn injury. Burns. 2018. PMID: 30545697. doi:10.1016/j.burns.2018.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。